Multidisciplinary Team (MDT) in Neuroendocrine Tumor (NET) Management: Results from the First Global NET Patient (pt) Survey - A Collaboration Between the International Neuroendocrine Cancer Alliance (INCA) and Novartis Pharmaceuticals

#1208

Introduction: Guidelines support an MDT approach to NETs. We present data on the global NET pt perspective regarding MDT care.

Aim(s): To assess the pt perspective on NET management and interactions with healthcare professionals (HCPs).

Materials and methods: Anonymous survey of NET pts from >12 countries conducted by INCA/Novartis in 2014 (Americas, Asia, Europe, Oceania) on the NET pt experience, including NET management and interactions with HCPs. All comparisons are significant at the P<0.05 level. This NET patient survey was a collaboration between INCA and Novartis and the survey was funded by Novartis.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Öberg K, Leyden J, Sissons M, Kolarova T, Goldstein G,

Keywords: Multidisciplinary team,